iifl-logo

DSP Nifty Healthcare Index Fund Direct G

DSP Nifty Healthcare Index Fund Direct G

Fund Name

DSP Mutual Fund

Scheme Name

DSP Nifty Healthcare Index Fund Direct G

AMC

DSP Mutual Fund

Type

:  Open

Category

Equity - Index

Launch Date

02-Jun-2025

Fund Manager

Anil Ghelani

Net Assets (Rs. cr)

17.19

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

DSP Nifty Healthcare Index Fund Direct G - Nav Details

Nav Date

:  25-Mar-2026

NAV [Rs.]

:  10.3156

Buy/Resale Price [Rs.]

0

Sell/Repurchase Price [Rs.]

0

Entry Load %

Nil

Exit Load %

Nil

DSP Nifty Healthcare Index Fund Direct G- NAV Chart

DSP Nifty Healthcare Index Fund Direct G- Performance(%)

Returns above 1 yr. are annualized

1W
1M
3M
6M
1Y
3Y
5Y
Since INC
Scheme Returns
0.35
-2.54
-1.43
0.49
-
-
-
3.15
Category Avg
-1.97
-8.17
-9.66
-6.5
1.2
16.44
12.3
3.54
Category Best
0.81
-1.4
2.45
15.06
37.21
32.23
19.1
37.21
Category Worst
-5.91
-13.46
-23.73
-22.89
-20.47
3.3
8.88
-29.26

DSP Nifty Healthcare Index Fund Direct G- Latest Dividends

No Records Found

DSP Nifty Healthcare Index Fund Direct G- Investment Details

Min. Investment(Rs.)

100

Increm.Investment(Rs.)

100

In & Out

In

InName Of The CompanyNo Of Shares
--

Out

InName Of The CompanyNo Of Shares
--

Fund Holdings

Asset Type
Instrument Name
Industry
Net Assets(%)
No of Shares
Mkt Value(Cr.)
Equity & Equity related Investments
EquitySun Pharma.Inds.Pharmaceuticals & Biotechnology18.32181273.14
EquityDivi's Lab.Pharmaceuticals & Biotechnology8.1121751.39
EquityMax HealthcareHealthcare Services8.09127311.39
EquityApollo HospitalsHealthcare Services8.0217621.37
EquityDr Reddy's LabsPharmaceuticals & Biotechnology7.81104321.34
EquityCiplaPharmaceuticals & Biotechnology7.5596321.29
EquityLupinPharmaceuticals & Biotechnology5.5641500.95
EquityFortis Health.Healthcare Services4.8989210.84
EquityTorrent Pharma.Pharmaceuticals & Biotechnology4.5117900.77
EquityLaurus LabsPharmaceuticals & Biotechnology4.1666510.71
EquityAurobindo PharmaPharmaceuticals & Biotechnology3.4047880.58
EquityAlkem LabPharmaceuticals & Biotechnology3.2810010.56
EquityGlenmark Pharma.Pharmaceuticals & Biotechnology3.2025780.55
EquityBioconPharmaceuticals & Biotechnology2.77122180.47
EquityMankind PharmaPharmaceuticals & Biotechnology2.5319360.43
EquityZydus Lifesci.Pharmaceuticals & Biotechnology2.3042830.39
EquityIpca Labs.Pharmaceuticals & Biotechnology2.1223790.36
EquityAbbott IndiaPharmaceuticals & Biotechnology1.37890.23
EquityPiramal PharmaPharmaceuticals & Biotechnology0.96105920.16
EquitySyngene Intl.Healthcare Services0.8032470.13

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

MY WEALTH AT RETIREMENT

Calculate the worth of your wealth at retirement

Key information

Fund House:
DSP Mutual Fund
Incorporation Date:
13-May-1996
Total Assets Managed (Cr.):
2,24,668.94
Trustee/s:
Mr.T.S. Krishna Murthy, DSP Trustee Private Limit, Shitin D. Desai, S.S.N. Moorthy, Mrs. Pravin tripathi, Ms. Dharmishta Rawal
Chairman:
NA
CEO / MD:
Mr. Kalpen Parekh
CIO:
NA
President:
NA
Director/s:
Uday Khanna, Mr.Hemendra M. Kothari, Mr. S.S. Mundra, Ms. Aditi Kothari Desai, Mr.Dhananjay Mungale, Mr. S. Ramadorai
Compliance Officer/s:
Pritesh Majmudar
Investor Service Officer/s:
NA
Fund Manager/s:
Anil Ghelani
Auditors:
S.R. BATLIBOI &Co.LLP, M/s.Walker Chandiok & Co.

OTHER INFORMATION

Registered Office:
The Ruby, 25th Floor, 29, Senapati Bapat Marg, Dadar (West), Mumbai - 400028.
Contact Nos:
022-66578000
Fax:
022-66578181
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.